ALEC (Alector) OCF Margin %: -4,762.24% (As of Mar. 2026)


ALEC Alector Inc ALEC
30 GF Score
Price $1.85
GF Value $0.73
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Alector OCF Margin %?

Alector ALEC +2.50% 30 OCF Margin % is -4,762.24% as of Mar. 2026. GuruFocus rates ALEC with a GF Score™ of 30/100 and a GF Value™ of $0.73 (Significantly Overvalued). The stock has 7 warning signs investors should review. Among 960 Biotechnology companies, Alector ranks worse than 79.48% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Alector's Cash Flow from Operations for the three months ended in Mar. 2026 was $-49.81 Mil. Alector's Revenue for the three months ended in Mar. 2026 was $1.05 Mil. Therefore, Alector's OCF Margin % for the quarter that ended in Mar. 2026 was -4,762.24%.

As of today, Alector's current OCF Yield % is -84.49%.

The historical rank and industry rank for Alector's OCF Margin % or its related term are showing as below:

ALEC' s OCF Margin % Range Over the Past 10 Years
Min: -3123.32   Med: -348.32   Max: 460.54
Current: -939.68


During the past 10 years, the highest OCF Margin % of Alector was 460.54%. The lowest was -3123.32%. And the median was -348.32%.

ALEC's OCF Margin % is ranked worse than
79.48% of 960 companies
in the Biotechnology industry
Industry Median: -68.59 vs ALEC: -939.68


Alector OCF Margin % Related Terms


Alector OCF Margin % Historical Data

* Premium members only.

The historical data trend for Alector's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alector OCF Margin % Chart

Alector Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 144.17 -15.21 -189.74 -228.63 -874.46

Alector Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,654.41 -622.89 -997.27 -668.45 -4,762.24

ALEC vs SLGL, LENZ, CNXU: OCF Margin % Comparison

For the Biotechnology subindustry, Alector's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alector OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alector's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Alector's OCF Margin % falls into.


ALEC
30GF Score
Alector Inc ALEC
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alector OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Alector's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-184.031/21.045
=-874.46 %

Alector's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-49.813/1.046
=-4,762.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -4,762.24% mean?
Alector (ALEC) has a OCF Margin % of -4,762.24% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Alector and its competitors. According to the industry distribution chart, Alector ranks #763 out of 960 companies in the Biotechnology industry, placing it in the top 79.5%.
Is Alector's OCF Margin % too high?
Alector's current OCF Margin % is -4,762.24%. Based on the distribution chart, Alector ranks #763 out of 960 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alector has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alector's OCF Margin % compare to SLGL and LENZ?
According to the Biotechnology industry distribution chart, Alector ranks #763 out of 960 companies for OCF Margin %. This places Alector in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Alector and its competitors. Alector's current OCF Margin % is -4,762.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alector stock overvalued right now?
Based on GuruFocus' analysis, Alector (ALEC) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.73, compared to a current price of $1.85 — trading 152.7% above its estimated fair value. The current OCF Margin % is -4,762.24%. Alector's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Alector (ALEC), the current OCF Margin % is -4,762.24% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alector (ALEC) Overvalued in 2026?

Based on GuruFocus' analysis, Alector stock appears to be overvalued. The current stock price of $1.85 is trading 152.7% above its estimated GF Value™ of $0.73. GuruFocus considers Alector to be Significantly Overvalued.

Key valuation signals for ALEC:

  • OCF Margin %: -4,762.24%
  • GF Value™: $0.73 vs. price of $1.85 (152.7% above fair value)
  • GF Score™: 30/100 with 7 warning signs

No single metric tells the full story. See the ALEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alector Business Description

Address 131 Oyster Point Boulevard, Suite 600, South San Francisco, CA, USA, 94080
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.
30GF Score

Get the complete analysis for ALEC

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.85
Price
$0.73
GF Value